Ability of Fractional Flow Reserve to Predict Restenosis after Superficial Femoral Artery Stenting

Journal of Endovascular Therapy

Volumn 23, Issue 6, 2016, Pages 896-902

  Kobayashi, Norihiro ^a   Hirano, Keisuke ^a   Yamawaki, Masahiro ^a   Araki, Motoharu ^a   Sakai, Tsuyoshi ^a   Takimura, Hideyuki ^a   Sakamoto, Yasunari ^a   Mori, Shinsuke ^a   Tsutsumi, Masakazu ^a   Takama, Takuro ^a   Honda, Yohsuke ^a   Tokuda, Takahiro ^a   Makino, Kenji ^a   Shirai, Shigemitsu ^a   Ito, Yoshiaki ^a  

^a SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

Author keywords

angioplasty; endovascular therapy; fractional flow reserve; nitinol stent; occlusion; restenosis; s uperficial femoral artery; stenosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN;

AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DUAL ANTIPLATELET THERAPY; FEMALE; FEMORAL ARTERY; FEMORAL ARTERY STENT; FRACTIONAL FLOW RESERVE; HUMAN; HYPEREMIA; IMPLANTATION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RESTENOSIS; SENSITIVITY AND SPECIFICITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTIVE VALUE; STENT; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMORAL ARTERY; HUMANS; MALE; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; STENTS; TREATMENT OUTCOME;

EID: 85009070253     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1177/1526602816668306     Document Type: Article

References (29)

1. Norgren L, Hiatt WR, Dormandy JA, et al.Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007; 45 (Suppl S): S5-S67.
2. European Stroke O, Tendera M, Aboyans V, et al.ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011; 32: 2851-2906.
3. Liistro F, Grotti S, Porto I, et al.Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv. 2013; 6: 1295-1302.
4. Tepe G, Laird J, Schneider P, et al.Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015; 131: 495-502.
5. ++ trial. Catheter Cardiovasc Interv. 2014; 84: 236-244.
6. Pijls NH, Fearon WF, Tonino PA, et al.Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol. 2010; 56: 177-184.
7. Pijls NH, Klauss V, Siebert U, et al.Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002; 105: 2950-2954.
8. Bech GJ, Pijls NH, De Bruyne B, et al.Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation. 1999; 99: 883-888.
9. Klauss V, Erdin P, Rieber J, et al.Fractional flow reserve for the prediction of cardiac events after coronary stent implantation: results of a multivariate analysis. Heart. 2005; 91: 203-206.
10. Samady H, McDaniel M, Veledar E, et al.Baseline fractional flow reserve and stent diameter predict optimal post-stent fractional flow reserve and major adverse cardiac events after bare-metal stent deployment. JACC Cardiovasc Interv. 2009; 2: 357-363.
11. Leesar MA, Satran A, Yalamanchili V, et al.The impact of fractional flow reserve measurement on clinical outcomes after transradial coronary stenting. EuroIntervention. 2011; 7: 917-923.
12. Nam CW, Hur SH, Cho YK, et al.Relation of fractional flow reserve after drug-eluting stent implantation to one-year outcomes. Am J Cardiol. 2011; 107: 1763-1767.
13. Ito T, Tani T, Fujita H, et al.Relationship between fractional flow reserve and residual plaque volume and clinical outcomes after optimal drug-eluting stent implantation: insight from intravascular ultrasound volumetric analysis. Int J Cardiol. 2014; 176: 399-404.
14. Iida O, Takahara M, Soga Y, et al.Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions. J Endovasc Ther. 2014; 21: 485-492.
15. Lotfi AS, Sivalingam SK, Giugliano GR, et al.Use of fraction flow reserve to predict changes over time in management of superficial femoral artery. J Interv Cardiol. 2012; 25: 71-77.
16. Hirsch AT, Haskal ZJ, Hertzer NR, et al.ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006; 113: e463-e654.
17. Kobayashi N, Hirano K, Nakano M, et al.Measuring procedure and maximal hyperemia in the assessment of fractional flow reserve for superficial femoral artery disease. J Atheroscler Thromb. 2016; 23: 56-66.
18. Pijls NH, De Bruyne B, Peels K, et al.Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996; 334: 1703-1708.
19. Ranke C, Creutzig A, Alexander K., Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol. 1992; 18: 433-440.
20. Youden WJ., Index for rating diagnostic tests. Cancer. 1950; 3: 32-35.
21. DeLong ER, DeLong DM, Clarke-Pearson DL., Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44: 837-845.
22. Schillinger M, Sabeti S, Loewe C, et al.Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006; 354: 1879-1888.
23. Krankenberg H, Schlüter M, Steinkamp HJ, et al.Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007; 116: 285-292.
24. Dick P, Wallner H, Sabeti S, et al.Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv. 2009; 74: 1090-1095.
25. Miki K, Fujii K, Fukunaga M, et al.Impact of post-procedural intravascular ultrasound findings on long-term results following self-expanding nitinol stenting in superficial femoral artery lesions. Circ J. 2013; 77: 1543-1550.
26. Mori S, Hirano K, Nakano M, et al.Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis. J Endovasc Ther. 2015; 22: 341-349.
27. Kasaoka S, Tobis JM, Akiyama T, et al.Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol. 1998; 32: 1630-1635.
28. Fujii K, Carlier SG, Mintz GS, et al.Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005; 45: 995-998.
29. Kang SJ, Mintz GS, Park DW, et al.Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis. Circ Cardiovasc Interv. 2011; 4: 9-14.